1. Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients. (4th May 2021) Authors: Elsamany, Shereef; Elsisi, Gihan Hamdy; Hassanin, Fayza; Jafal, Mohamed Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 21:Number 3(2021) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗